273 related articles for article (PubMed ID: 31655816)
21. Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.
Patel A; Roshkovan L; McNulty S; Alley E; Torigian DA; Nachiappan AC; Galperin-Aizenberg M; Barbosa EM; DiRienzi J; Berger I; Khalid U; Haas AR; Singhal S; Wileyto EP; Cengel KA; Katz SI
Clin Lung Cancer; 2021 May; 22(3):210-217.e1. PubMed ID: 32693945
[TBL] [Abstract][Full Text] [Related]
22. Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions.
Froudarakis ME; Plojoux J; Kaspi E; Anevlavis S; Laroumagne S; Karpathiou G; Roca E; Adler D; Dutau H; Astoul P
Clin Respir J; 2018 Mar; 12(3):1011-1016. PubMed ID: 28245530
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic features of erionite-induced malignant mesothelioma.
Demirer E; Ghattas CF; Radwan MO; Elamin EM
Yonsei Med J; 2015 Mar; 56(2):311-23. PubMed ID: 25683976
[TBL] [Abstract][Full Text] [Related]
24. A rare case of primary gastric Burkitt's lymphoma associated with malignant pleural mesothelioma.
Spaziani E; Di Filippo AR; Valle G; Spaziani M; Francioni P; Caruso G; Tamagnini GT; Mosciatti E; Picchio M; De Cesare A
Ann Ital Chir; 2023 Mar; 12():. PubMed ID: 36924064
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis.
Miyoshi S; Sasada S; Izumo T; Matsumoto Y; Tsuchida T
PLoS One; 2016; 11(11):e0167186. PubMed ID: 27880851
[TBL] [Abstract][Full Text] [Related]
26. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos.
Okten F; Köksal D; Onal M; Ozcan A; Simşek C; Ertürk H
Clin Imaging; 2006; 30(3):177-80. PubMed ID: 16632152
[TBL] [Abstract][Full Text] [Related]
27. The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines.
Sinha S; Swift AJ; Kamil MA; Matthews S; Bull MJ; Fisher P; De Fonseka D; Saha S; Edwards JG; Johns CS
Clin Radiol; 2020 Jun; 75(6):423-432. PubMed ID: 32081346
[TBL] [Abstract][Full Text] [Related]
28. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
29. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial.
Metintas M; Ak G; Dundar E; Yildirim H; Ozkan R; Kurt E; Erginel S; Alatas F; Metintas S
Chest; 2010 Jun; 137(6):1362-8. PubMed ID: 20154079
[TBL] [Abstract][Full Text] [Related]
30. Computed Tomographic Features of Malignant Peritoneal Mesothelioma.
Kato K; Gemba K; Fujimoto N; Aoe K; Takeshima Y; Inai K; Kishimoto T
Anticancer Res; 2016 Mar; 36(3):1067-72. PubMed ID: 26976999
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
Metintas M; Ucgun I; Elbek O; Erginel S; Metintas S; Kolsuz M; Harmanci E; Alatas F; Hillerdal G; Ozkan R; Kaya T
Eur J Radiol; 2002 Jan; 41(1):1-9. PubMed ID: 11750145
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.
Battolla E; Canessa PA; Ferro P; Franceschini MC; Fontana V; Dessanti P; Pinelli V; Morabito A; Fedeli F; Pistillo MP; Roncella S
Anticancer Res; 2017 Mar; 37(3):1387-1391. PubMed ID: 28314308
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis.
Martinez-Zayas G; Molina S; Ost DE
Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36543349
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F
Arch Bronconeumol; 2015 Apr; 51(4):177-84. PubMed ID: 25059587
[TBL] [Abstract][Full Text] [Related]
35. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
[TBL] [Abstract][Full Text] [Related]
36. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
[TBL] [Abstract][Full Text] [Related]
38. Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT.
Hwang JH; Song KS; Park SI; Lim TH; Kwon KH; Goo DE
Korean J Radiol; 2005; 6(2):94-101. PubMed ID: 15968148
[TBL] [Abstract][Full Text] [Related]
39. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
40. Malignant Pleural Mesothelioma: Are There Imaging Characteristics Associated With Different Histologic Subtypes on Computed Tomography?
Escalon JG; Harrington KA; Plodkowski AJ; Zheng J; Capanu M; Zauderer MG; Rusch VW; Ginsberg MS
J Comput Assist Tomogr; 2018; 42(4):601-606. PubMed ID: 29613986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
